SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001640455-23-000102
Filing Date
2023-05-04
Accepted
2023-05-04 07:29:32
Documents
1
Effectiveness Date
2023-05-04

Document Format Files

Seq Description Document Type Size
1 S-8 POS jnce05032023forms-8postxef.htm S-8 POS 45980
  Complete submission text file 0001640455-23-000102.txt   46973
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-236687 | Film No.: 23886476
SIC: 2836 Biological Products, (No Diagnostic Substances)